Physician

Alvin C Wee, MD

According to 2025 Medicare claims, Alvin Wee, MD (NPI: 1558539874) practices urology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is THE CLEVELAND CLINIC FOUNDATION (NPI: 1679525919; TIN: 340714585) and primary practice location at 44195-0001. Wee is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729), Cleveland Clinic Florida Integrated Health (ACO ID: A3588), and Vandalia Health Network (ACO ID: A4513), participating under the MSSP model.

Wee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 124 traditional Medicare patients, billed 327 HCPCS/CPT codes, and received $105,181 in Medicare payments. The top billing code was 50360 (Transplantation of donor kidney). Part D data shows 81 prescription claims across 12 beneficiaries totaling $934 in drug costs, led by Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim). DME data shows 53 claims. Open Payments data shows 15 records totaling $4,235. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $61,325 to $105,181. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $319,272 to $934. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $226 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	90	368	$61,325
2016	69	272	$41,271
2017	90	323	$68,367
2018	150	502	$110,601
2019	149	571	$128,074
2020	162	610	$146,610
2021	197	551	$135,095
2022	164	470	$125,995
2023	123	348	$86,961
2024	124	327	$105,181

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	152	3,320	$319,272
2016	158	1,598	$170,065
2017	80	368	$25,585
2018	60	241	$45,333
2019	58	245	$32,617
2020	60	197	$38,925
2021	72	234	$32,216
2022	71	273	$21,300
2023	27	88	$3,373
2024	12	81	$934

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	570	3,340	$363,728
2016	519	2,074	$211,717
2017	131	565	$43,822
2018	76	149	$10,490
2019	70	211	$9,750
2020	12	60	$2,123
2021	28	53	$2,021
2022	50	167	$4,698
2023	N/R	139	$15,295
2024	N/R	53	$19,858

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
50360	Transplantation of donor kidney	31	31	$1,702
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	27	27	$113
52310	Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope	43	43	$109
50327	Preparation of donor kidney and veins for transplantation	25	26	$76
99238	Hospital discharge day management, 30 minutes or less	23	23	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	690	$184
Amlodipine Besylate	Amlodipine Besylate	12	360	$84
Atorvastatin Calcium	Atorvastatin Calcium	12	540	$55
Finasteride	Finasteride	12	480	$24

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	24	$19,431
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	15	$239
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	14	$188

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$4,235	Globus Medical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alvin C. Wee, MD?

Tedicare shows public-source Medicare data for Alvin C. Wee, MD (NPI 1558539874), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alvin C. Wee, MD have ACO affiliation data?

Alvin C. Wee, MD is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729), Cleveland Clinic Florida Integrated Health (MSSP, ACO ID A3588), and Vandalia Health Network (MSSP, ACO ID A4513).

What billing organization is linked to Alvin C. Wee, MD?

Alvin C. Wee, MD is linked to THE CLEVELAND CLINIC FOUNDATION (billing NPI 1679525919) in the available physician profile data.

Does Alvin C. Wee, MD have Open Payments data?

Alvin C. Wee, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.